GSK Plc Correlations
| G1SK34 Stock | BRL 39.60 0.15 0.38% |
The current 90-days correlation between GSK plc and Dell Technologies is 0.08 (i.e., Significant diversification). The correlation of GSK Plc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
GSK |
The ability to find closely correlated positions to GSK Plc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GSK Plc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GSK Plc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GSK plc to buy it.
Moving together with GSK Stock
Moving against GSK Stock
| 0.75 | TSMC34 | Taiwan Semiconductor | PairCorr |
| 0.66 | CEAB3 | CA Modas SA | PairCorr |
| 0.55 | AAPL34 | Apple Inc | PairCorr |
| 0.5 | BRSR5 | Banco do Estado | PairCorr |
| 0.45 | S1MF34 | Sumitomo Mitsui Financial | PairCorr |
| 0.4 | NMRH34 | Nomura Holdings | PairCorr |
| 0.37 | H1DB34 | HDFC Bank Limited | PairCorr |
| 0.36 | SNEC34 | Sony Group Split | PairCorr |
Related Correlations Analysis
| -0.48 | 0.42 | 0.9 | 0.82 | 0.93 | D1EL34 | ||
| -0.48 | -0.1 | -0.52 | -0.49 | -0.36 | LUPA3 | ||
| 0.42 | -0.1 | 0.58 | 0.71 | 0.47 | TTEN3 | ||
| 0.9 | -0.52 | 0.58 | 0.86 | 0.86 | S1PO34 | ||
| 0.82 | -0.49 | 0.71 | 0.86 | 0.84 | P1YC34 | ||
| 0.93 | -0.36 | 0.47 | 0.86 | 0.84 | M2RV34 | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between GSK Stock performing well and GSK Plc Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze GSK Plc's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| D1EL34 | 1.99 | 0.41 | 0.15 | 0.86 | 1.95 | 5.14 | 11.42 | |||
| LUPA3 | 1.51 | (0.19) | 0.00 | (0.25) | 0.00 | 3.52 | 17.30 | |||
| TTEN3 | 1.57 | 0.32 | 0.11 | (4.54) | 1.54 | 3.82 | 18.93 | |||
| S1PO34 | 1.84 | 0.71 | 0.21 | (1.19) | 2.16 | 3.11 | 18.04 | |||
| P1YC34 | 1.64 | 0.73 | 0.21 | (0.99) | 0.83 | 5.29 | 36.37 | |||
| M2RV34 | 1.79 | 0.49 | 0.14 | 8.62 | 1.82 | 5.43 | 11.71 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in GSK Plc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
GSK Plc Corporate Management
Elected by the shareholders, the GSK Plc's board of directors comprises two types of representatives: GSK Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GSK. The board's role is to monitor GSK Plc's management team and ensure that shareholders' interests are well served. GSK Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GSK Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Redfern | Chief Officer | Profile | |
| Diana Conrad | Chief Officer | Profile | |
| Emma Walmsley | CEO Director | Profile | |
| Sally Jackson | VP Office | Profile | |
| Iain Mackay | CFO Director | Profile | |
| James Ford | Sr Compliance | Profile | |
| Shobie Ramakrishnan | Chief Officer | Profile |